Alvotech

Alvotech is a biotechnology company founded by Robert Wessman, focusing on the development and production of biosimilars for patients worldwide. Alvotech is committed to becoming a global leader in the biosimilars field by providing high-quality, cost-effective products and services through a fully integrated approach and extensive internal capabilities. Alvotech's current pipeline includes eight biosimilar candidates aimed at treating autoimmune diseases, ocular conditions, osteoporosis, respiratory diseases, and cancer.